Yn dangos 496 i 510 o 2073 canlyniadau
HCPC gender, ethnicity and disability pay gaps report 2024
Annual reports on the gender and ethnicity pay gaps, with this year marking the first publication of the disability pay gap.
Education annual data set: 2018-19 academic year
Snapshot of outcomes related to the HCPC’s education function for the 2018-19 academic year
Commonly asked record-keeping questions, answered
Katherine Timms, Head of Policy and Standards at the HCPC, answers the most common questions we receive from registrants about record keeping
Protected function - hearing aid dispensers
We regulate hearing aid dispensers on the basis of their professional title and also their protected function.
Multiple Registrant Search
Search the Register for up to 100 professionals at a time
HCPC response to DHSC healthcare regulation consultation
As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.
HCPC responds to the Government’s regulatory reform consultation
“An important step towards modernising and reforming professional regulation”
Before we begin
The first page you’ll see is the ‘Before we begin’ page
Chiropodists, podiatrists and hearing aid dispensers renewal window closing soon
The deadline for chiropodists, podiatrists and hearing aid dispensers to complete their registration renewal is fast approaching
Understanding the Duty of Candour- new resources available for you
New materials outline what candour means and what it looks like in practice.
Higher and Degree Apprenticeships Review Report 2019-20
Snapshot of outcomes related to higher and gegree apprenticeships for the academic year 2019-20
Legal Assessor
Legal Assessors are legally qualified and provide advice to panels of the HCPC’s statutory committees and Council on questions of law
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)